Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maximus (MMS) Cash & Equivalents (2016 - 2025)

Maximus (MMS) has disclosed Cash & Equivalents for 17 consecutive years, with $137.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents changed N/A to $137.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $137.6 million, a N/A change, with the full-year FY2025 number at $222.4 million, up 21.42% from a year prior.
  • Cash & Equivalents was $137.6 million for Q4 2025 at Maximus, down from $222.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $222.4 million in Q3 2025 to a low of $59.8 million in Q2 2025.
  • A 5-year average of $133.7 million and a median of $122.1 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 118.26% in 2021, then fell 21.12% in 2022.
  • Maximus' Cash & Equivalents stood at $202.6 million in 2021, then dropped by 21.12% to $159.8 million in 2022, then fell by 3.96% to $153.5 million in 2023, then grew by 19.3% to $183.1 million in 2024, then fell by 24.86% to $137.6 million in 2025.
  • Per Business Quant, the three most recent readings for MMS's Cash & Equivalents are $137.6 million (Q4 2025), $222.4 million (Q3 2025), and $59.8 million (Q2 2025).